Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook ® , LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms .
Patent and License Information: standardbio.com/legal/notices .
©2025 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Standard BioToolsLABNGS:LABbiotech investing
LAB
The Conversation (0)
NevGold Intercepts Consistent Oxide Antimony-Gold Mineralization in All Drillholes From Historic Crushed Leach Pad Including 0.32% Antimony And 0.39 g/t Au Over 14.9 Meters

NevGold Intercepts Consistent Oxide Antimony-Gold Mineralization in All Drillholes From Historic Crushed Leach Pad Including 0.32% Antimony And 0.39 g/t Au Over 14.9 Meters

Nevgold Corp. ("NevGold" or the "Company") (TSXV:NAU,OTC:NAUFF) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce positive, consistent antimony ("Sb") and gold ("Au") mineralization in all drillholes from the historic Crushed leach pad (see Key Highlights and Appendix I - Drillhole Summary... Keep Reading...
Bunker Hill Confirms Discovery of New High-Grade Silver-Lead Veins with Second Drill Intercept

Bunker Hill Confirms Discovery of New High-Grade Silver-Lead Veins with Second Drill Intercept

Drillhole BHE26-02 returns: Continuous mineralization over 28.6 ft grading 3.02 oz/ton (103.39 g/t) silver, 7.44% lead and 0.85% zinc (173.5 g/t AgEq) starting at 453 ft downhole, including 17.1 ft at 4.19 oz/ton (143.64 g/t) silver, 10.67% lead and 0.73% zinc (238.05 g/t AgEq) Two distinct... Keep Reading...
Providence Gold Reports Up to 8.0 g/t Au from Mojave Girl Stockpile Sampling; Phase 2 Evaluation at Tarantula Site To Begin

Providence Gold Reports Up to 8.0 g/t Au from Mojave Girl Stockpile Sampling; Phase 2 Evaluation at Tarantula Site To Begin

(TheNewswire) Providence Gold Mines Inc. (TSX-V: PHD | OTC: PRRVF | Frankfurt: 7RH1-F) ("Providence" or the "Company") reports positive gold assay results from the first phase of continuous surface stockpile sampling at the La Dama de Oro property, located near the city of Victorvile,... Keep Reading...
Brixton Metals Drills 13.0m of 594 g/t Silver Including 0.5m of 7,900 g/t Silver at its Langis Project

Brixton Metals Drills 13.0m of 594 g/t Silver Including 0.5m of 7,900 g/t Silver at its Langis Project

Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the "Company" or "Brixton") is pleased to announce the fourth batch of results from its ongoing exploration at the wholly owned Langis Silver Project, located in the historic silver mining camp of Cobalt, Ontario, Canada. The 2026 drill... Keep Reading...
Standard Uranium Intersects Anomalous Radioactivity and Graphitic Reactivated Structure at Rocas Uranium Project; Initial Drill Program Complete

Standard Uranium Intersects Anomalous Radioactivity and Graphitic Reactivated Structure at Rocas Uranium Project; Initial Drill Program Complete

Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce that drilling activities have been completed at the Company's Rocas Uranium Project ("Rocas", or the "Project") located 75 kilometers southwest of the Key Lake... Keep Reading...
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+

BriaCell expands push in women's health, building on Phase 2 success in advanced metastatic breast cancerBria-OVA+, BriaCell's next generation personalized immunotherapy candidate for ovarian cancer, is designed with additional immune-stimulating components to support enhanced anti-tumor... Keep Reading...
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer

Bria-PROS+ is BriaCell's next generation personalized off-the-shelf immunotherapy for prostate cancerImmune stimulating components of Bria-PROS+ enhance anti-tumor responsesBriaCell has completed manufacturing clinical supplies of Bria-PROS+ and plans to initiate a Phase 1/2a clinical study in... Keep Reading...
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Other recently activated sites include Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Virginia (UVA) Comprehensive Cancer Center, Baptist Health South Florida, and SCRI Oncology Partners briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell"... Keep Reading...
Glowing DNA strand against blue background with digital graphs and glowing bars.

Hantavirus Outbreak Sparks Rollercoaster Ride for Biotech Stocks

A localized hantavirus outbreak aboard an Atlantic cruise ship triggered a brief, speculative frenzy in biotechnology stocks this week.Shares of prominent vaccine developers fluctuated on Monday (May 11) as retail investors attempted to front run what they perceived as a burgeoning global health... Keep Reading...
BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients

BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients

Over 315 patients screened and over 230 patients enrolled in BriaCell's pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancer Enrollment momentum continues with strong clinical site and patient interestInterim topline data expected in... Keep Reading...
BriaCell Therapeutics (TSX:BCT)

BriaCell Therapeutics: Redefining Oncology with Personalized Cancer Immunotherapy

Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

$2.5m Raised to Fast Track Stage 2 Drilling at Music Well

Trading Halt

Trading Halt

Drilling Approval Received & IP Survey Completed at Armidale

Related News

base metals investing

$2.5m Raised to Fast Track Stage 2 Drilling at Music Well

gold investing

Trading Halt

base metals investing

Trading Halt

precious metals investing

Drilling Approval Received & IP Survey Completed at Armidale

precious metals investing

Red Mountain Mining Limited Drilling Approval Received and IP Survey Completed at Armidale

base metals investing

VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update

copper investing

Top 5 Canadian Mining Stocks This Week: Mogotes Metals Gains 159 Percent